| Gamma-aminobutyric acid receptor subunit pi | 8 | 0 | 2 | 10 |
| Lysine-specific demethylase 6B | 0 | 2 | 0 | 2 |
| Lysine-specific demethylase 4B | 0 | 2 | 0 | 2 |
| Heat shock protein HSP 90-alpha | 0 | 5 | 4 | 9 |
| Heat shock protein HSP 90-beta | 0 | 3 | 4 | 9 |
| Cholesteryl ester transfer protein | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit delta | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 0 | 2 | 10 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 0 | 2 | 10 |
| Lysine-specific demethylase 5A | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 0 | 2 | 10 |
| Endoplasmin | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 0 | 2 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 0 | 2 | 10 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 1 |
| GABA theta subunit | 8 | 0 | 2 | 10 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 8 | 0 | 2 | 10 |
| Lysine-specific demethylase 4C | 0 | 2 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
| USP1 protein, partial | 6 | 0 | 0 | 6 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| AR protein | 10 | 0 | 0 | 10 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
| farnesoid X nuclear receptor | 8 | 0 | 0 | 8 |
| estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 7 | 0 | 0 | 7 |
| geminin | 14 | 0 | 0 | 14 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| Histone deacetylase 3 | 0 | 5 | 0 | 5 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Histone deacetylase 4 | 0 | 4 | 0 | 4 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Histone deacetylase 1 | 0 | 7 | 0 | 7 |
| Histone deacetylase 7 | 0 | 4 | 0 | 4 |
| Histone deacetylase 2 | 0 | 7 | 0 | 7 |
| Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
| Histone deacetylase 11 | 0 | 4 | 0 | 4 |
| Ataxin-2 | 3 | 0 | 0 | 3 |
| Histone deacetylase 8 | 0 | 5 | 0 | 5 |
| Histone deacetylase 6 | 0 | 5 | 0 | 5 |
| Histone deacetylase 9 | 0 | 3 | 0 | 3 |
| Histone deacetylase 5 | 0 | 4 | 0 | 4 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| TDP1 protein | 8 | 0 | 0 | 8 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| thioredoxin reductase | 5 | 0 | 0 | 5 |
| GLS protein | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 7 | 0 | 0 | 7 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
| Chain A, Cruzipain | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 6 | 0 | 0 | 6 |
| SMAD family member 3 | 6 | 0 | 0 | 6 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
| estrogen-related nuclear receptor alpha | 9 | 0 | 0 | 9 |
| pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| caspase-3 | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| caspase-3 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 8 | 0 | 0 | 8 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 4 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 5 |
| Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | 9 | 0 | 0 | 9 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 5 |
| polyprotein | 3 | 0 | 0 | 3 |
| Calpain-9 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
| Interferon beta | 4 | 0 | 0 | 4 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
| Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
| Aromatase | 0 | 2 | 0 | 2 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-1 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
| NF-kappa-B inhibitor alpha | 0 | 0 | 1 | 1 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
| Cathepsin K | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
| Gamma-secretase subunit PEN-2 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| Smad3 | 3 | 0 | 0 | 3 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
| G | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| IDH1 | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 1 | 5 |
| Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
| Luciferase | 3 | 0 | 0 | 3 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| perilipin-5 | 0 | 2 | 0 | 2 |
| perilipin-1 | 0 | 2 | 0 | 2 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| ATP-citrate synthase | 0 | 0 | 0 | 1 |
| Ribonuclease T | 0 | 0 | 0 | 1 |
| Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| Nrf2 | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 3 | 0 | 0 | 3 |
| alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| toll-like receptor 9 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
| hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Phospholipase A2 | 0 | 1 | 1 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 2 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 2 | 0 | 2 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 2 | 1 | 4 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
| Histone acetyltransferase p300 | 0 | 2 | 0 | 2 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
| Sortase A | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 2 | 0 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
| Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
| Interferon regulatory factor 3 | 0 | 0 | 1 | 1 |
| Stimulator of interferon genes protein | 0 | 0 | 2 | 2 |
| Stimulator of interferon genes protein | 0 | 1 | 2 | 3 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| Chain A, DigA16 | 0 | 0 | 1 | 1 |
| Chain A, DigA16 | 0 | 0 | 1 | 1 |
| PAX8 | 0 | 0 | 0 | 1 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
| Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 0 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 0 | 0 | 3 |
| Neutral amino acid transporter A | 0 | 3 | 0 | 3 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 3 | 0 | 3 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Amino acid transporter | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 3 | 0 | 5 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 5 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 4 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 4 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 4 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Trypsin | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 19 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Exportin-1 | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
| NS5 | 0 | 0 | 1 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 0 | 1 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Corticotropin releasing hormone receptor 2 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
| ATP-dependent molecular chaperone HSP82 | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Breakpoint cluster region protein | 0 | 1 | 0 | 1 |
| ATP-dependent molecular chaperone HSC82 | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
| Heat-shock protein | 0 | 1 | 0 | 1 |
| Putative heat shock protein HSP 90-alpha A4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Sodium/bile acid cotransporter | 0 | 0 | 0 | 2 |
| Ileal sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| Bile salt export pump | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |